Rare diseases
Investigational molecules
Locations
Back to France458 clinical trials in Amiens, France across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on Ivabradine for Heart Rate Control and Survival in Adults with Septic Shock
FranceStudy Comparing Lenalidomide, Daratumumab, and Dexamethasone for Frail Patients with Untreated Multiple Myeloma Not Eligible for High-Dose Therapy
FranceStudy on MaaT013 for Treating Acute Gastrointestinal Graft-Versus-Host Disease in Patients Not Responding to Ruxolitinib
FranceStudy of Teclistamab with Daratumumab or Lenalidomide for Elderly Patients with Newly Diagnosed Multiple Myeloma
FranceStudy on Treosulfan, Fludarabine Phosphate, and Thiotepa for Patients with Myelofibrosis Undergoing Haplo-identical Transplantation
FranceStudy on Adding Nivolumab to Cisplatin and Radiotherapy for High-Risk Patients with Head and Neck Squamous Cell Carcinoma
FranceStudy Comparing Abelacimab and Apixaban for Preventing Blood Clots in Cancer Patients
FranceStudy on Itacitinib for Treating Non-Severe Hemophagocytic Lymphohistiocytosis in Adults
FranceStudy on Itacitinib for Adults with Diffuse Systemic Sclerosis
FranceStudy of Pembrolizumab with Drug Combination for Patients with Microsatellite Stable Metastatic Colorectal Cancer with High Immune Infiltrate
FranceStudy Comparing Gilteritinib and Midostaurin with Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with FLT3 Mutation
FranceStudy on the Safety of Lutetium (177Lu) Oxodotreotide with Arginine and Lysine in Children with Refractory or Recurrent Neuroblastoma
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on head and neck cancers and multiple myeloma treatments. Studies include novel combination therapies and targeted approaches for improved patient outcomes.
Research emphasizes personalized treatment approaches combining immunotherapy with conventional treatments.
Comprehensive research into heart failure prevention and chronic kidney disease management, with focus on innovative therapeutic combinations.
Trials exploring new drug combinations and surgical interventions for improved cardiovascular outcomes.
Studies investigating treatments for Crohn's Disease and other inflammatory conditions, including innovative microbiota-based approaches.
Focus on developing targeted therapies and investigating treatment discontinuation strategies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
